Epidemic prevention and control, we are in action
Release time:
2022-03-22
News from this newspaper Jinhua Jindong District "3.13" after the emergence of the epidemic, in order to do a good job in the prevention and control of the new coronary pneumonia epidemic, to ensure the health and safety of employees, the group company and in the gold subordinate enterprises actively deployed, the implementation of the prevention and control work.
3# July 13 , jindong district of Jinhua City found 1 cases of new coronary pneumonia positive infection, involving Hu Lingqiao Village, Dongxiao Street, jindong district, Shunfeng Express Jinhua Transfer, Tangya Town Hanxiang Village, epidemic prevention department 13 has carried out the first round of large-scale full nucleic acid testing in relevant areas, some areas of Jindong District are designated as closed control area, control area and prevention area. After the outbreak of the epidemic, the Group headquarters and the enterprises in the gold actively responded, informed the spread of the epidemic, arranged epidemic prevention and control measures, the implementation of epidemic prevention and control work. In addition to further emphasizing the daily prevention and control measures, the Group also focused on epidemic prevention, work arrangements, express delivery, goods receipt management and disinfection of employees in the epidemic-related areas according to the characteristics of the epidemic. In addition to doing a good job of prevention and control measures in accordance with local prevention and control requirements, enterprises also further strengthen the prevention and control of the epidemic according to their own actual situation.
Cable Company used the morning meeting platform to organize all employees to conduct training on epidemic prevention and control measures, including doing well in employee health management, maintaining ventilation in the workplace, cleaning and disinfecting the working and living places, reducing employee gathering and collective activities, doing well in medical services, strengthening prevention and control publicity and education, implementing personal protection requirements, etc., in order to improve employees' epidemic prevention and control ability and response level, and enhance scientific prevention awareness, strengthen the staff's sense of responsibility, enhance the sense of urgency, and do a good job of self-protection of employees.
Peak Health Technology Company invited relevant leaders of Jinhua Wucheng District Economic and Commercial Bureau to the enterprise to guide the epidemic prevention measures for cranberry raw materials to be imported next month. At the meeting, the two sides exchanged information on the traceability of imported goods, the loading and unloading areas of the factory, the conditions for setting up warehouses and the killing arrangements for key places and personnel, and formulated prevention and control plans and emergency plans for imported goods to ensure the smooth progress of the import business and the safe and orderly epidemic prevention work. Some raw materials in Jinxi factory of pharmaceutical company are imported raw materials. Jinxi factory does a good job in epidemic prevention and control management of imported goods in strict accordance with the "Operational Procedures for Normalized Epidemic Prevention and Control of Imported Goods by Industrial Enterprises in Zhejiang Province (Trial)", carries out daily health monitoring and management of relevant personnel, and has special personnel to register the information of key personnel. Nucleic acid testing is incorporated into Jinhua's online epidemic prevention supervision. Direct contact with imported goods personnel to carry out nucleic acid testing once every two days, non-direct contact with other key personnel to carry out nucleic acid testing once every seven days, these two types of personnel to carry out information registration, "Jinhua epidemic prevention online platform " daily test whether key personnel according to once every two days or once every seven days to carry out nucleic acid testing.
Jinhua Pharmaceutical Company gives full play to the role of the Party organization as a fighting fortress and the vanguard and exemplary role of Party members, organizes Party members to provide good services, strengthens the elimination of public places and the inspection of personnel entering and leaving, takes the lead in publicizing and urging personnel around them to abide by the epidemic prevention and control regulations, and firmly builds the first line of defense against the new crown epidemic to ensure the health and safety of enterprise employees.
The epidemic has a greater impact on the peak international trading company, peak international trade rental of the South Station warehouse and SF Express Jinzhong transfer adjacent, was identified as the control area, the implementation of "only in and out, people out of the area, no gathering " control measures. All employees in the South Railway Station warehouse were affected, some were isolated locally, some were isolated centrally or at home. On the morning of 3 May 14 , Jianfeng International Trade immediately held an epidemic prevention and control meeting to sort out the personnel control situation, on-site killing situation, epidemic prevention material reserve situation, business impact situation, as well as the latest epidemic prevention and control policies and trends of the government, check and fill gaps, implement the main responsibility of epidemic prevention and control and the government control requirements, and improve the emergency plan. In particular, it is emphasized to do a good job in the life security, dynamic and psychological counseling of the isolated and controlled personnel, and to inquire about the situation of the isolated and controlled personnel by telephone every day, so as to understand the needs in time and do a good job in emotional comfort. Jianfeng International Trade also organizes a meeting after work every day to understand and summarize the epidemic prevention and control situation on that day, and the dynamic monitoring of personnel makes a daily report to ensure timely understanding of the epidemic prevention and control situation of employees and the factory area. In addition, Jianfeng International Trade has also made further rectification and arrangements for the implementation of epidemic prevention and control by outsourcing units, tenants, construction units, and security guards, strengthening inspection and supervision in the park, and doing a good job in logistical support.
Due to the ban on the South Station warehouse, some of the business has also been affected, Peak International Trade in the prevention and control of the epidemic at the same time, for warehousing, transportation business upstream and downstream customers and exchanges, do a good job of communication and next work arrangements. The South Station warehouse has a daily business volume of ,000-2000 tons. After the South Station warehouse was banned, Jianfeng International Trade responded in a timely manner, adjusting the business to the nearest station and Xiaohuang Village and Shoe Tang reservoir areas, increasing the delivery volume of the two reservoir areas, and at the same time, communicating with upstream and downstream customers to ensure the normal operation of the business.
According to the information released by the Jinhua epidemic prevention department, since the outbreak of the epidemic, jindong district has carried out seven rounds of nucleic acid testing in the areas of close connection, sub-close connection and Dongxiao Street control area, control area and prevention area, and the test results are all negative. At present, the peak international trade to accept the outbreak management staff, in good health.
(Ni YingzhenFan Tufa Huang Yuan Chen Yueping)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page